Showing results (161-170 of 5,263) with videos related to

Sort By:
Pageof 527
European Journal of Haematology|May 22, 2015
Risk factors for non-melanoma skin cancer in patients with essential thrombocythemia and polycythemia veraMontse Gómez, Vicent Guillem, Arturo Pereira, et al.
European Journal of Haematology|May 22, 2015
Early MRD response as a prognostic factor in adult patients with acute lymphoblastic leukemiaCyril Šálek, František Folber, Eva Froňková, et al.
European Journal of Haematology|May 8, 2015
Molecular diagnostics of myeloproliferative neoplasmsStephen E Langabeer, Hajnalka Andrikovics, Julia Asp, et al.
European Journal of Haematology|May 6, 2015
Polymorphisms of IL-10 affect the severity and prognosis of myelodysplastic syndromeTetsuhiro Kasamatsu, Takayuki Saitoh, Yusuke Minato, et al.
European Journal of Haematology|May 13, 2015
Tumour-associated mast cells in classical Hodgkin's lymphoma: correlation with histological subtype, other tumour-infiltrating inflammatory cell subsets and outcomeMaja D Andersen, Peter Kamper, Patricia S Nielsen, et al.
European Journal of Haematology|May 1, 2020
Clinical benefit of ixazomib plus lenalidomide-dexamethasone in myeloma patients with non-canonical NF-κB pathway activationAjeeta B Dash, Jacob Zhang, Lei Shen, et al.
European Journal of Haematology|April 13, 2020
Prevalence of pyruvate kinase deficiency: A systematic literature reviewMatthew H Secrest, Mike Storm, Courtney Carrington, et al.
European Journal of Haematology|May 5, 2020
Erythropoietin treatment in chronic phase chronic myeloid leukemia patients treated with frontline imatinib who developed late anemiaLaura Cesini, Camilla Frieri, Claudia Baratè, et al.
European Journal of Haematology|May 1, 2020
Monosomal karyotype affecting outcomes of allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia in first complete remissionYunsuk Choi, Je-Hwan Lee, Jung-Hee Lee, et al.
European Journal of Haematology|April 18, 2020
R-DHA-oxaliplatin (R-DHAOx) versus R-DHA-cisplatin (R-DHAP) regimen in B-cell lymphoma treatment: A eight-year trajectory studyCarole Lacout, Corentin Orvain, Valérie Seegers, et al.
Pageof 527